
The Library Media — National & World · National Desk
Federal Judge Bars HIV Funding Conditions That Punished Acknowledging Transgender Patients
By Eleanor Ever Loyal
Photo: 83DegreesMedia / Wikimedia Commons (CC BY 2.0)
A federal judge in Boston ruled on Thursday that the Trump administration cannot impose conditions on providers receiving federal HIV treatment funds that bar them from acknowledging transgender patients’ gender identities or providing gender-affirming care.
U.S. District Judge William Young, a Reagan appointee, issued the ruling in a 165-page decision following a non-jury trial in September. The conditions had been added to grants under the Ryan White HIV/AIDS Program beginning in March by the Health Resources and Services Administration (HRSA), the Department of Health and Human Services division responsible for administering the programme.
The Ryan White programme dates to 1990 and helps low-income and uninsured people with HIV obtain access to treatment. The new grant conditions implemented President Donald Trump’s executive orders concerning what the administration calls “gender ideology” and its policy of recognising only two sexes.
According to the lawsuit, the conditions required recipients to ensure that funded activities supported the use of “sex-based definitions grounded in biological reality” and did not involve what the policy described as “social or medical experimentation.” The restrictions applied to providers receiving programme funds and, under the conditions challenged in court, prevented them from acknowledging transgender patients’ gender identities or offering gender-affirming care.
The plaintiffs, national HIV medical associations and providers including the American Academy of HIV Medicine, challenged the conditions on constitutional grounds. They also argued that the policy conflicted with the statutory mandate of the Ryan White programme, which has historically included hormone therapy among the care available to people with HIV.
Young concluded that the conditions violated both the First and Fifth Amendments to the U.S. Constitution. He found that they were designed to suppress what the administration regarded as “dangerous ideas”, penalising medical providers for acknowledging the existence of transgender people and for using patients’ preferred pronouns.
The First Amendment finding concerned restrictions on what providers could acknowledge or communicate in their work with patients. Young also held that the conditions violated the Fifth Amendment through sex discrimination.
In his decision, Young sharply criticised the basis and effect of the restrictions.
“They are based in animus, loathing, and discrimination. They do not stand for justice – in fact, they defy it. They are contrary to the laws of this nation and cannot continue to stand,” he wrote.
The ruling addresses conditions attached to a longstanding federal programme intended to help people with HIV obtain treatment. The plaintiffs had argued that the restrictions not only imposed constitutional limits on providers’ ability to acknowledge transgender patients and deliver care, but also conflicted with the programme’s established statutory purpose and history, including its coverage of hormone therapy.
The Department of Health and Human Services did not immediately respond to a request for comment. Lawyers for the plaintiffs also did not immediately respond to a request for comment.
Reuters reported the decision and the parties’ responses. The reporting did not specify whether the order was preliminary or permanent, or describe its geographic scope. It also did not report any subsequent appeal step.
Eleanor Ever Loyal
Lead Counsel & National Desk, The Library Media
From The Library — the estate of our family.
Follow Us
